Genexine Market Cap

Genexine has a market cap or net worth of 221.03 billion as of March 9, 2026. Its market cap has increased by 8.36% in one year.

Market Cap

221.03B

Enterprise Value

n/a

Revenue

5.81B

Ranking

n/a

PE Ratio

n/a

Stock Price

4,860.00

Market Cap Chart

Since September 15, 2009, Genexine's market cap has increased from 109.02B to 221.03B, an increase of 102.74%. That is a compound annual growth rate of 4.38%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	231.04B	8.43%
Dec 30, 2025	213.07B	-12.27%
Dec 30, 2024	242.86B	-40.82%
Dec 28, 2023	410.35B	-12.73%
Dec 29, 2022	470.21B	-67.78%
Dec 30, 2021	1,459.20B	-52.47%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
iNtRON Biotechnology	197.72B
EASY BIO,Inc.	227.60B
Vaxcell-Bio Therapeutics	195.13B
HLB Therapeutics	235.50B
Macrogen	185.06B
MedPacto	178.57B
ENCell	165.35B
Helixmith	294.70B

Market Cap Rankings